当前位置:首页 - 行情中心 - 诚意药业(603811) - 财务分析 - 现金流量表

诚意药业

(603811)

  

流通市值:31.48亿  总市值:31.48亿
流通股本:4.58亿   总股本:4.58亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金437,434,233.06193,017,611.48809,619,848.71595,513,096.94
  收到的税费返还--339,886.57339,886.57
  收到其他与经营活动有关的现金12,620,861.914,193,385.3318,971,818.813,357,099.15
  经营活动现金流入小计450,055,094.97197,210,996.81828,931,554.08609,210,082.66
  购买商品、接受劳务支付的现金75,443,000.939,571,174.13126,210,691.39102,697,104.75
  支付给职工以及为职工支付的现金70,029,996.9732,600,619.24113,889,563.9989,481,907.32
  支付的各项税费71,490,778.2529,410,318.47103,571,790.7582,855,405.89
  支付其他与经营活动有关的现金92,223,810.0741,399,938.55204,869,829.17137,220,320.62
  经营活动现金流出小计309,187,586.19142,982,050.39548,541,875.3412,254,738.58
  经营活动产生的现金流量净额140,867,508.7854,228,946.42280,389,678.78196,955,344.08
二、投资活动产生的现金流量:
  收回投资收到的现金60,000,000---
  取得投资收益收到的现金45,370.63-11,250,50011,250,500
  处置固定资产、无形资产和其他长期资产收回的现金净额968,695.78968,095.7838,983,398.5216,372.5
  投资活动现金流入小计61,014,066.41968,095.7850,233,898.511,466,872.5
  购建固定资产、无形资产和其他长期资产支付的现金36,570,322.6424,155,644.6845,401,719.8818,195,905.22
  投资支付的现金150,000,000---
  投资活动现金流出小计186,570,322.6424,155,644.6845,401,719.8818,195,905.22
  投资活动产生的现金流量净额-125,556,256.23-23,187,548.94,832,178.62-6,729,032.72
三、筹资活动产生的现金流量:
  吸收投资收到的现金--48,286,35648,286,356
  取得借款收到的现金39,199,123.0927,307,889.7365,696,975.9655,000,000
  筹资活动现金流入小计39,199,123.0927,307,889.73113,983,331.96103,286,356
  偿还债务支付的现金10,100,00010,000,000258,560,000168,960,000
  分配股利、利润或偿付利息支付的现金98,607,309.8235,657.5983,477,203.4183,028,520.65
  支付其他与筹资活动有关的现金--9,153,972.849,154,208.84
  筹资活动现金流出小计108,707,309.810,235,657.59351,191,176.25261,142,729.49
  筹资活动产生的现金流量净额-69,508,186.7117,072,232.14-237,207,844.29-157,856,373.49
四、汇率变动对现金及现金等价物的影响-136,510.82-33,789.28-348,075.78-282,320.02
五、现金及现金等价物净增加额-54,333,444.9848,079,840.3847,665,937.3332,087,617.85
  加:期初现金及现金等价物余额217,113,850.99217,113,850.99169,447,913.66169,447,913.66
  期末现金及现金等价物余额162,780,406.01265,193,691.37217,113,850.99201,535,531.51
补充资料:
  净利润95,752,192.66-197,465,207.06-
  资产减值准备4,311,636.47-11,737,649.89-
  固定资产和投资性房地产折旧45,617,962.61-92,371,766.12-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧45,617,962.61-92,371,766.12-
  无形资产摊销972,641.22-2,314,462.73-
  长期待摊费用摊销108,898.68-210,776.16-
  处置固定资产、无形资产和其他长期资产的损失-61,711.69--21,064,523.22-
  固定资产报废损失60,647.33-470,237.26-
  财务费用527,195.58-4,145,965.09-
  投资损失-11,156,545.21--33,104,348.34-
  递延所得税-3,478,401.28--3,331,414.46-
  其中:递延所得税资产减少-2,661,491.73--1,697,595.39-
    递延所得税负债增加-816,909.55--1,633,819.07-
  存货的减少2,074,118.02-8,065,535.86-
  经营性应收项目的减少-47,242,245.85--41,042,107.18-
  经营性应付项目的增加21,939,629.53-38,958,164.11-
  其他32,105,136.36-23,819,939.86-
  现金的期末余额162,780,406.01-217,113,850.99-
  减:现金的期初余额217,113,850.99-169,447,913.66-
  现金及现金等价物的净增加额-54,333,444.98-47,665,937.33-
公告日期2026-08-272026-04-242026-04-242025-10-28
审计意见(境内)标准无保留意见
TOP↑